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The intestinal protozoan parasite Giardia  lamblia  is the causative agent of a 
condition  known  as  giardiasis,  which is  quickly becoming a  major worldwide 
public health concern. In several surveys of apparently healthy populations in 
the  United  States,  2-22%  of the  screened individuals  tested  positive  for  G. 
lamblia infections (1-4). 
Giardiasis is a debilitating disease characterized by severe diarrhea, abdominal 
pain, anorexia, and stunted growth in children. Mammals become infected with 
G. lamblia through ingestion of food or water contaminated with G. lamblia cysts. 
Currently there is no satisfactory treatment for giardiasis; the two drugs available, 
metronidazole (Flagyi) and quinacrine (Atabrine), both produce undesirable side 
effects. 
It has become increasingly apparent in recent years that parasite metabolism 
can differ significantly from that of the mammalian host, and that these differ- 
ences can be viewed as attractive targets for the design of antiparasitic agents. 
As an example, many parasitic protozoa examined to date have been found to 
lack purine de novo synthesis and thus depend exclusively on salvage of preformed 
purines to  supply necessary purine nucleotide needs (5-9).  Trypanosoma  cruzi 
and  Leishmania  donovani  are  two  examples  whose dependence on  salvage of 
purines has been successfully exploited in designing antitrypanosomal and anti- 
leishmanial agents effective in controlling the parasite without ill effects to the 
host (10-12).  Recently (13), we have observed that G.  lamblia also lacks de novo 
purine synthesis and relies on a very simple scheme of purine salvage involving 
a guanine phosphoribosyltransferase and an adenine phosphoribosyltransferase. 
In  contrast  to  the  deficiency of purine  de  novo  synthesis,  most  protozoan 
parasites are fully capable of synthesizing pyrimidine nucleotides de novo. How- 
ever,  two  anaerobic,  flagellated  parasitic  protozoa,  Tritrichomonas foetus  and 
Trichomonas vaginalis have been found (14,  15) to lack de novo synthesis of both 
purine  and  pyrimidine  nucleotides,  and  thus  rely  on  salvage  of exogenous 
purines, pyrimidines, and their nucleosides to satisfy metabolic needs. These two 
organisms were also found (14,  15) to lack dihydrofolate reductase and thymi- 
dylate synthetase, and must rely on salvage of exogenous thymidine for DNA 
synthesis. In addition, Lindmark and Jarroll (16) have suggested that G.  lamblia 
lacks de novo pyrimidine metabolism, as indicated by its inability to incorporate 
orotate or aspartate into cold trichloroacetic acid-insoluble fractions and by the 
absence of de  novo  pyrimidine synthesis enzymes. In  previous  studies (Wang, 
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unpublished results), it was found that G. lamblia also lacks dihydrofolate reduc- 
tase and thymidylate synthetase. 
These results indicate that G. lamblia, like T.foetus and T. vaginalis, is incapable 
of both purine and pyrimidine de novo biosynthesis and must rely on the host to 
provide for its nucleotide needs. This dependence on the host would be of critical 
importance to the survival of the parasite. 
It was our aim in this study to verify this dependence on salvage of pyrimidines 
by  G.  lamblia  and  to  establish  the  pyrimidine  salvage  pathway  used  by  this 
parasite.  This  information could  then  be  used  to propose  rational  targets  for 
design of antigiardial agents. 
Materials and Methods 
G.  lamblia Cultures.  The G.  lamblia Portland I  strain was a  generous gift from Dr. 
Donald Lindmark of Cornell University. G. lamblia trophozoites were cultivated axenically 
in vitro under anaerobic conditions at 37 °C in Diamond's BI-S-33 medium, pH 7.05 (17); 
with the following modifications: (a) sterilization of the medium was by filtration through 
a 0.22 •m  Millipore filter (Millipore/Continentai Water Systems, Bedford, MA); (b) the 
vitamin-Tween 80 mixture was eliminated from the medium. Cultures reached stationary 
phase after 96 h of growth and had a final cell density of 2 ×  106/ml. These cultures were 
used to inoculate fresh media at a 2:10 ratio. Mid-log phase growth was achieved after 74 
h incubation with a cell density of 106/ml.  These cells were harvested and used for all 
studies.  Cell  countings  were  routinely performed  in  a  Coulter  ZF  counter  (Coulter 
Electronics Inc., Hialeah, FL). 
Chemicals.  Radiolabeled orotate, aspartate, bicarbonate, pyrimidines, and pyrimidine 
nucleosides were purchased from New England Nuclear, Boston, MA; ICN Pharmaceu- 
ticals,  Inc., Irvine, CA; or Amersham Corp., Arlington Heights, IL. All other chemicals 
used in the studies were of the highest purities commercially available. 
Precursor Incorporation into Nucleotide Pools.  G. lamblia harvested by centrifugation at 
3,000 g for 5 min was washed three times and resuspended in phosphate-buffered saline 
glucose (20 mM), pH 7.0, with 2 mM cysteine, to a final cell density of 2 ×  107/ml, and 
incubated at 37 °C. Radiolabeled substrates were each added to the cell suspension to a 
final concentration of 40 t~M, and aliquots were taken at various time intervals. Aliquots 
of 300 ul were taken for uptake studies of [5,6-SH]uracil, [5,6-SH]uridine, [2-~4C]cytosine 
and  [5-3H]cytidine. Aiiquots of 3  ml,  concentrated  10-fold to  300  #1,  were taken for 
uptake studies of [6-14C]orotate,  [2,3-SH]aspartate, [~4C]bicarbonate,  [2-~4C]thymine, and 
[2-14C]thymidine.  Each aliquot was treated with perchloric acid-KOH and filtered through 
glass  fiber filters loaded with  polyethyleneimine (PEI)~-cellulose  in  5  mM  ammonium 
acetate, pH 5.0, as previously described (9). The nucleotide-loaded filter was washed with 
three 5-ml  portions of the ammonium acetate buffer, dried, and soaked in Aquasol  2 
(New England Nuclear). Levels of radioactivity were determined with a liquid scintillation 
spectrometer (LS-3133T; Beckman Instruments, Inc., Fullerton, CA). 
High Performance Liquid  Chromatography (HPLC).  Pyrimidine nucleotides were sepa- 
rated, identified, and quantitated in an ion-exchange HPLC system with an Ultrasil AX 
(10 #m; Beckman Instruments,  Inc., Fullerton, CA) 4.6 ×  250 mm column. Perchloric 
acid-KOH extracts of incorporation experiments concentrated fivefold ([5,6-3H]uracil, 
[5,6-3H]uridine, [2-z4C]cytosine, [5-~H]cytidine)  or 10-fold ([6-~4C]orotate,  [2,3-3H]aspar  - 
tate, [~4C]bicarbonate,  [2:~4C]thymine, [2-~4C]thymidine)were injected (100 #l)and eluted 
with  7  mM  phosphate buffer, pH  3.8,  at a  flow rate of 1.0  ml/min.  A  programmed 
gradient elution, from 7 mM phosphate buffer, pH 3.8, to 250 mM phosphate buffer, 
pH 4.5, plus 500 mM  KCI, was applied. The effluent was monitored at 254 nm in an 
I Abbreviations used in this paper:  CMP,  cytidine monophosphate; HPLC, high performance liquid 
chromatography;  PEI,  polyethyleneimine;  TMP,  ribosylthymine  monophosphate;  UMP, uridine 
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ultraviolet (UV)-absorbance detector (Beckman Instruments, Inc.), mixed with Aquasol 2 
at a  1:3  ratio, and  the radioactivity recorded in a  radioactive flow detector (Flo-one; 
Radiomatic Instruments & Chemical Co.,  Inc., Tampa, FL). Both UV absorbance and 
radioactivity data were recorded and analyzed by 3390A integrator (Hewlett-Packard 
Co., Palo Alto, CA) (9). 
For analysis of pyrimidine bases and nucleosides, a reverse phase HPLC system with an 
ODS (5 ~m; Beckman Instruments,  Inc.) reverse phase column was used, eluted with a 
programmed gradient, from 7 mM KH~PO4, pH 6.0, to 50% acetonitrile, at a flow rate 
of 0.75 ml/min. UV monitoring and continuous radioactivity measurement of the effluent 
were as previously described (9). 
Enzyme Assays.  Mid-log phase G. lamblia trophozoites were washed and resuspended 
in an equal volume of 25 mM Tris-HCl, pH 7.2, 20 mM KCI, 6 mM MgCI~, and 1 mM 
dithiothreitol (TKMD). Cells were disrupted, using a sonicator (Heat Systems-Ultrasonics, 
Inc., Farmingdale, NY), in an ice bath, for three 10-s pulses at an output setting of 4 and 
duty cycle setting of 40. The homogenate was centrifuged at 104g for 30 min to remove 
cell debris.  The crude supernatant fraction was  then centrifuged at  10  s g  for  1 h  to 
separate the soluble and peiletable fractions. Protein concentrations were determined by 
the method of Lowry et al. (18), with bovine serum albumin as the standard. 
Pyrimidine phosphoribosyl transferases were assayed according to a modified procedure 
by Schmidt et al. (19). The reaction mixture, containing 100 ~! of 100 mM Tris-HCl, pH 
7.8, 8 mM MgCI2, 1.0 mM 5-phosphoribosyl-l-pyrophosphate (PRPP), 50 #g/mi bovine 
14  14  serum albumin, and 200 uM of [2-  C]cytosine (61 mCi/mmol), or [2-  C]uracil (53 mCi/ 
mmol) was  incubated at  37°C.  The reaction, initiated by adding enzyme sample,  was 
terminated by adding an equal volume of ice-cold, 5 mM ammonium acetate, pH  5.0. 
Aliquots of the mixture were filtered through PEI-cellulose and the trapped radioactivities 
were counted as described previously. 
Pyrimidine nucleoside kinases were assayed by a procedure similar to that described by 
Nelson et al.  (11).  The assay mixture, consisting of 100 mM Tris-HCl, pH 7.5, 20 mM 
ATP, 20 mM MgCI2, 30 mM phosphoenolpyruvate, 40 IU/ml pyruvate kinase, and 0.2 
mM  of [53H]cytidine (48  mCi/mmol),  [5,63H]uridine  (52.1  mCi/mmol),  or  [2-14C]  - 
thymidine (58.4  mCi/mmol), was  incubated at  37°C  for  10  min after the addition of 
enzyme. The reaction was stopped by a 10-fold dilution of the reaction mixture in cold 5 
mM ammonium acetate, pH 5.0. The PEI-adsorbable radioactivity was measured. 
Pyrimidine nucleoside phosphotransferases were assayed by using p-nitrophenylphos- 
phate (10  mM) as  the  phosphate donor in an  assay  mixture containing  100  mM  Na- 
acetate, pH 5.4,  0.2 mM of the radiolabeled pyrimidine nucleosides, and the enzyme. 
Assay procedures were the same as for the kinases. 
Pyrimidine nucleoside hydrolase was assayed in TKMD with  1.0 mM of a pyrimidine 
nucleoside in the absence of added phosphate for varying lengths of time, terminated by 
perchloric acid, neutralized with KOH, and the reaction products analyzed by reverse 
phase HPLC to identify and quantitate the pyrimidine bases. 
Cytosine/cytidine deaminase was assayed in  50 mM  Tris HCI, pH  7.5 and 0.2  mM 
substrate. Reaction was initiated by addition of enzyme and then incubated at 37°C for 
varying lengths of time. The reaction was terminated by perchloric acid-KOH treatment. 
The extract was then analyzed by reverse phase HPLC. 
Results 
De Novo Pyrimidine Synthesis.  Log phase  G.  lamblia  cells were  incubated  at 
37°C with [~4C]bicarbonate (50 mCi/mmol),  [634C]orotic acid (61  mCi/mmol), 
or [2,33H]L-aspartic acid (28.7  mCi/mmol) for 60  rain.  Perchloric acid-KOH 
extracts of cell suspensions concentrated  10-fold were analyzed by PEI cellulose 
absorption and HPLC. No radioactivity could be detected in pyrimidine nucleo- 
tides of G. lamblia. 
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pyrimidines or pyrimidine nucleosides were tested for incorporation into the G. 
lamblia  nucleotide pool, all  substrates except thymine were incorporated to a 
detectable level (Fig.  1).  Uridine and uracil were incorporated at the highest 
initial rate of 2.25 pmol/min per 106 cells, followed by cytosine and cytidine at 
an initial rate of 0.8 pmol/min per 106 cells. Thymidine was incorporated at the 
lowest rate, 0.2 pmoi/min per 106 cells, and was detected only after time point 
aliquots were concentrated 10-fold and assayed for PEI  absorption.  Thymine 
incorporation was below the minimal level of detection (0.08 pmol/min per 106 
cells) even after we incubated samples for 60 min and concentrating them  10- 
fold. 
HPLC Analysis  of Radiolabeled  Nucleotide Pools.  When perchloric acid-KOH 
extracts of cells incubated for 60 rain with []4C]HCOs-, [6J4C]orotate, [2,3-3H]  - 
aspartate, or [2J4C]thymine were analyzed by HPLC, no radiolabel incorporation 
into nucleotide pools could be detected. 
HPLC profiles of G. lamblia nucleotide pools after incubation with either [5,6- 
~H]uracil, [5,6-~H]uridine, [2-14C]cytosine,  or [5-SH]cytidine all showed a similar 
pattern. Radioactivity was observed in both the uracil nucleotides and cytosine 
nucleotides after pulse labeling for 45 rain (Fig. 2). [5,6>H]uracil and [5,6-~H]  - 
uridine had  similar  incorporation  profiles,  with  radioactivity found predomi- 
nantly as uridine monophosphate (UMP), UDP-hexose, UTP, and, to a smaller 
extent, UDP. However, substantial radioactivity was found associated with cyti- 
dine  monophosphate  (CMP),  CDP,  and  CTP.  Similarly, when either  [2-I4C] - 
cytosine or [5-3H]cytidine was used as the radioactive precursor, radioactivity 
was equally distributed into CMP, CDP, and CTP as well as UMP, UDP, UDP- 
hexose, and UTP. 
These data  indicate  that  there  is  extensive conversion between pyrimidine 
nucleoside uridine and  cytidine nucleotides.  This  interconversion could  take 
place at the pyrimidine or pyrimidine nucleoside level or between pyrimidine 
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FIGURE  1.  Incorporation of radiolabeled pyrimidines and pyrimidine nucleosides  into the 
nucleotide pool of G.  lamblia.  [5,6bH]uracil (52 mCi/mmol) (0); [5,6-SH]uridine  (52.1  mCi/ 
mmol) (O); [2)4Clcytosine (61  mei/rnmol) (&); [5>H]cytidine (48  mei/mmol) (A); [2-14C]- 
thymine (54 mCi/mmol) (I); [2J4e]thymidine (58.4 mei/mmol) (rl). Each data point was from 
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FIGUl~E  2.  HPLC  analysis  of G.  larablia nucleotide  pool  pulse-labeled  by 40  #M  of [2J4C] - 
cytosine  (61  mCi/mmol)  or [5,6-SH]uridine  (52.1  rnCi/rnmol). 
nucleoside triphosphates, using an enzyme similar to that found in other systems: 
a cytidine triphosphate synthetase (20-23). 
HPLC analysis of [2-14C]thymidine incorporation into G.  lamblia  nucleotide 
pools  quantitated  radioactivity  exclusively  in  three  peaks,  corresponding  to 
ribosylthymine monophosphate (TMP), TDP, and TTP (data not shown). 
Enzyme Assays.  The results of various enzyme assays from G. lamblia  soluble 
and  pellet  fractions  are  summarized  in  Table  I.  Thymidine  salvage  occurs 
apparently through a thymidine phosphotransferase that is found mainly in the 
105g pellet fraction, with only residual activity in the supernatant fraction. Very 
low amounts of thymidine kinase activities [0.0123-0.0142 nmol/(min, mg)] were 
detected in the pellet and supernatant fractions. 
One of the major enzyme activities in the supernatant fraction of G.  lamblia 
crude extracts was uracil phosphoribosyltransferase, which is apparently respon- 
sible for salvaging and converting exogenous uracil to UMP. A uridine phospho- 
transferase was also present in the supernatant fraction when uridine is used as 
a substrate and p-nitrophenyiphosphate as the phosphate donor for the formation 
of UMP. No uridine kinase or cytidine kinase activities could be detected in the 
pellet or supernatant fractions of the extracts. 
Other enzymes exhibiting extremely high levels of activity in G. lamblia  were 
thymidine hydrolase and uridine hydrolase. Cytidine hydrolase was present at a 
much lower level. These enzymes, which convert thymidine, uridine, and cytidine 
to their corresponding pyrimidine bases, are not dependent upon the presence 
of orthophosphate for their activities and are thus unlikely to be phosphorylases. 
The relatively low level of cytidine hydrolase may be due to the extremely high 
amount of cytidine deaminase activity found in  the supernatant  fraction.  No 
cytosine deaminase enzyme activities were detected in either the supernatant or 
pellet fraction. However, cytosine can be salvaged by the cytosine phosphoribo- 442  PYRIMIDINE  SALVAGE  IN  GIARDIA LAMBLIA 
TABLE  I 
Pyrimidine Salvage Enzymes in G. lamblia Trophozoites 
Enzyme 
Specific activity [nmol/(min • mg) protein] 
Pellet  Supernatant 
Thymidine kinase  0.0142  4- 0.007  0.0123 4- 0.001 
Uridine kinase  <0.001  <0.001 
Cytidine kinase  <0.001  <0.001 
Thymidine phosphotransferase 
Uridine phosphotransferase 
Cytidine phosphotransferase 
Uracil phosphoribosyhransferase 
Cytosine phosphoribosyltransferase 
0.090 4- 0.003  0.01505 4- 0.0045 
0.058 4- 0.019  <0.001 
<0.001  <0.001 
0.025 +  0.004  1.87 4- 0.62 
<0.001  0.1325 4- 0.04 
Thymidine hydrolase  <0.001  155 4- 18 
Uridine hydrolase  <0.001  168 4- 14 
Cytidine hydrolase  <0.001  7.6 4- 0.4 
Cytidine deaminase  <0.001  183 4- 33 
Cytosine deaminase  <0.001  <0.001 
Each data value was from four independent experiments. 
syltransferase activity present at a  low level in  the supernatant fraction of G. 
lamblia. 
Discussion 
Our investigation has confirmed the absence of de novo pyrimidine nucleotide 
synthesis in G.  lamblia, caused by the failure to detect incorporation of orotate, 
bicarbonate, or aspartate into the G.  lamblia pyrimidine nucleotides pool. This 
result agrees with observations published earlier by Lindmark and Jarroll (16), 
who could not detect the de novo pyrimidine synthesis enzymes. 
From our results we are able to propose a fairly simple scheme of pyrimidine 
salvage by G. lamblia, which is summarized in Fig. 3. Incorporation of uracil into 
UMP by uracil phosphoribosyltransferase seems to be the predominant pathway 
supplying pyrimidine nuc]eotides.  Uridine  is  mostly converted to  uracil  first, 
because of the very high level of uridine hydrolase in G.  larablia, before incor- 
poration  into  UMP  via  uracil  phosphoribosyltransferase.  This  conclusion  is 
supported by the similar incorporation rates of radiolabeled uracil and uridine, 
as well as the HPLC profiles of their radioactive nucleotide pools. These HPLC 
profiles also indicate that labeled uracil or uridine give rise to radioactive peaks 
corresponding not only to UMP, UDP-hexose, UDP, and UTP, but also to CMP, 
CDP, and CTP.  This indicates an active conversion from uracil nucleotides to 
cytosine nucleotides, probably by the action of cytidine triphosphate synthetase 
(20-23). 
The HPLC profile of cytidine incorporation is similar to those of uracil and 
uridine, indicating that it too is shuttled through the uracil salvage pathway. This 
is  confirmed by  the substantial  amount of cytidine deaminase activity in  the ALDRITT, TIEN, AND WANG 
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FIGURE 3.  The pyrimidine  salvage  pathway  in G. larablia: (1) uracil phosphoribosyhransfer- 
ase, (2) uridine hydrolase,  (3) uridine phosphotransferase,  (4) cytidine  deaminase,  (5) cytidine 
hydrolase,  (6) cytosine  phosphoribosyhransferase,  (7) thymidine  phosphotransferase. 
crude extract of G.  lamblia,  which converts nearly all  the available cytidine to 
uridine within minutes. The uridine is then rapidly hydrolyzed to uracil before 
incorporation into the pyrimidine nucleotide pool. A  small amount of cytidine 
might be hydrolyzed to the corresponding base cytosine, which could be incor- 
porated into the nucleotide pool by the action of cytosine phosphoribosyltrans- 
ferase. 
HPLC analysis of the radioactive nucleotide pool after incubation of G. lamblia 
trophozoites with radiolabeled cytosine revealed labeled CMP, CDP, and CTP 
peaks, as well as  UMP,  UDP,  UDP-hexose, and  UTP peaks.  The labeling of 
UMP,  UDP-bexose, UDP, and  UTP cannot be readily explained, because we 
did  not  detect cytosine deaminase activity deaminating cytosine to  uracil,  or 
cytosine phosphorylase activity converting cytosine to cytidine, in the soluble or 
pelletable fractions of G.  lamblia.  Direct conversion of cytosine nucleotides to 
uracil nucleotides has not yet been demonstrated in G.  lamblia crude extracts. 
When we incubated soluble fractions of G. lamblia for various time intervals with 
CMP,  and analyzed  the  enzyme extract  by  ion  exchange and  reverse phase 
HPLC,  we  detected no  UMP  formation  but  significant  amounts  of uridine, 
uracil, cytidine, and cytosine (data not shown). We believe that the phosphatase 
and hydrolase activities of G.  lamblia  may account for the formation of uracil 
nucleotides  from  cells  incubated  with  radiolabeled  cytosine.  CMP  could  be 
converted  to  cytidine  by  the  phosphatase  and  then  to  uridine  by  cytidine 
deaminase. Uracil generated from uridine could then be recycled through uracil 
phosphoribosyltransferase and incorporated into UMP, UDP, and UTP.  CMP 
could also be converted to CDP and CTP, presumably by kinase actions. These 
activities may account for the parallel increase in radioactivity of cytosine nucleo- 
tide peaks as compared with uracil nucleotide peaks in HPLC profiles of cytosine- 
labeled G.  lamblia nucleotides. 
G.  lamblia  must rely on the salvage of exogeneous thymidine via thymidine 
phosphotransferase to satisfy its nucleic acid needs. This is supported by the fact 
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The estimated rate of thymidine incorporation, 0.2 pmol/min per 106 cells (Fig. 
1)  corresponds  to  an  incorporating  activity  of 0.025  nmol/(min.mg) protein 
(there is 8 #g protein in the peiletable fraction of 106 G.  lamblia trophozoites). 
The  specific  activity  of  thymidine  phosphotransferase  (0.09  nmol/(min.mg) 
protein, Table  I) is more than adequate  to supply all  the TMP needed by G. 
lamblia. There is also evidence of thymidine kinase activity in G.  lamblia, but at 
such a  low level  (Table  I)  that  it  is  not likely a  primary  means of supplying 
thymidine nucleotides. 
These results indicate that salvage of pyrimidines by G.  lamblia is very similar 
to that reported (14) for pyrimidine salvage by T. foetus, which also is primarily 
dependent  on  the  activity  of uracil  phosphoribosyltransferase  and  thymidine 
phosphotransferase to supply necessary nucleotides. The parasite T. vaginalis has 
been  found (15) to depend on a  membrane-bound deoxyribonucleoside phos- 
photransferase  for all  deoxynucleotides. It would be interesting to investigate 
the  various  substrate  specificities  of the  thymidine  phosphotransferase  of G. 
lamblia to determine if it is a similar type of enzyme. 
Obviously, the uracil phosphoribosyltransferase and thymidine phosphotrans- 
ferase are particularly attractive  targets for antigiardial drug design, since the 
activity of these two enzymes seems crucial to the survival of the parasite. Future 
work  will  concentrate  on  the  purification  and  characterization  of these  two 
enzymes. 
Summary 
We  have  found  that  the  anaerobic  protozoan  parasite  Giardia  lamblia  is 
incapable of de novo pyrimidine metabolism, as shown by its inability to incor- 
porate orotate, bicarbonate, and aspartate into the pyrimidine nucleotide pool. 
Results from high performance liquid chromatography of pyrimidine and pyrim- 
idine nucleoside pulse-labeled nucleotide pools and enzyme assays suggest that 
the  parasite  satisfies  its  pyrimidine  nucleotide  needs  predominantly  through 
salvage of uracil by a  cytoplasmic uracil phosphoribosy|transferase.  Exogenous 
uridine and cytidine are primarily converted to uracil by the action of uridine 
hydrolase and  cytidine deaminase before incorporation  into nucleotide pools. 
Direct  salvage  of cytosine  occurs  to  a  relatively  limited  extent  via  cytosine 
phosphoribosyltransferase.  G.  lamblia relies on salvage of exogenous thymidine 
for  ribosylthymine  monophosphate  (TMP)  synthesis,  accomplished  primarily 
through the action of a  100,000 g-pelletable thymidine phosphotransferase. 
Received for publication  1 November 1984. 
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